| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/08/2007 | WO2007014455A1 Cancerous disease modifying antibodies |
| 02/08/2007 | WO2007014420A1 Method for identifying regulatory t cells |
| 02/08/2007 | WO2006131599A3 Method of profiling a cell population |
| 02/08/2007 | WO2006126219A8 Liver progenitor cells |
| 02/08/2007 | WO2006121923A3 Cns cells in vitro |
| 02/08/2007 | WO2006113647A3 Recovery of tissue function following administration of b cells to injured tissue |
| 02/08/2007 | WO2006065975A8 Methods of treating ankylosing spondylitis using anti-tnf antibodies and peptides of human tumor necrosis factor |
| 02/08/2007 | WO2005115525A3 Devices and methods for protecting against distal embolisms |
| 02/08/2007 | WO2004044124A3 Identification of oligoadenylate synthetase-like genes |
| 02/08/2007 | US20070033677 Plant sHSP gene bidirectional promoter and uses thereof |
| 02/08/2007 | US20070033674 Flavanoid 3',5' hydroxylase gene sequences and uses therefor |
| 02/08/2007 | US20070033673 Annexin and p34 promoters and use in expression of transgenic genes in plants |
| 02/08/2007 | US20070033672 Inbred corn line BE9515 |
| 02/08/2007 | US20070033671 Polynucleotides and polypeptides in plants |
| 02/08/2007 | US20070033670 Wheat plants having increased tolerance to imidazolinone herbicides |
| 02/08/2007 | US20070033669 Semaphorin gene family |
| 02/08/2007 | US20070033668 Inbred miniature swine and uses thereof |
| 02/08/2007 | US20070033666 Using cytosine deaminases to diminish retroelement transfer from pigs to humans |
| 02/08/2007 | US20070033665 Unactivated oocytes as cytoplast recipients for nuclear transfer |
| 02/08/2007 | US20070033664 Quiescent cell populations for nuclear transfer |
| 02/08/2007 | US20070033663 ES cells having enhanced RNAi effect |
| 02/08/2007 | US20070033662 GLP-2 receptor gene promoter and uses thereof |
| 02/08/2007 | US20070033661 Suppression of B-cell apoptosis in transgenic animals expressing humanized immunoglobulin |
| 02/08/2007 | US20070032961 Apparatus and method for automated protein design |
| 02/08/2007 | US20070032635 Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes |
| 02/08/2007 | US20070032445 Antisense IAP nucleobase oligomers and uses thereof |
| 02/08/2007 | US20070031966 Renal progenitor cells from embryonic stem cells |
| 02/08/2007 | US20070031965 Chimeric molecules that contain at least one pathogen-detection domain and at least one effector domain; use in preventing or treating a pathogen infection in a cell or organism |
| 02/08/2007 | US20070031964 Myeloma cell culture in transferrin-free low iron medium |
| 02/08/2007 | US20070031947 Transgenic amorpha-4, 11-diene synthesis |
| 02/08/2007 | US20070031945 High mannose proteins and methods of making high mannose proteins |
| 02/08/2007 | US20070031940 Methods for inducing differentiation of undifferentiated mammalian cells into osteoblasts |
| 02/08/2007 | US20070031938 Organic anion transporting (oat)-like protein ust3-like1 and uses thereof |
| 02/08/2007 | US20070031936 Nucleic acid sequences having gene transcription regulatory qualities |
| 02/08/2007 | US20070031935 Nucleic acid sequences having gene transcription regulatory qualities |
| 02/08/2007 | US20070031934 Nucleic acid sequences having gene transcription regulatory qualities |
| 02/08/2007 | US20070031933 Determining whether a DNA sequence comprises a gene transcription modulating quality and/or a gene transcription repressing quality; systematic elucidation and identification of regulatory sequences |
| 02/08/2007 | US20070031932 Cultures of E1-immortalized cells and processes for culturing the same to increase product yields therefrom |
| 02/08/2007 | US20070031929 Polypeptides Homologous To VEGF and BMP1 |
| 02/08/2007 | US20070031920 High expression locus vector based on ferritin heavy chain gene locus |
| 02/08/2007 | US20070031904 Mammalian IAP gene family, primers, probes and detection methods |
| 02/08/2007 | US20070031903 Mammalian IAP gene family, primers, probes and detection methods |
| 02/08/2007 | US20070031896 Anti-CCR4 antibodies and methods of use therefor |
| 02/08/2007 | US20070031888 Human leucine-rich repeat containing protein expressed predominately in small intestine, HLRRSI1 |
| 02/08/2007 | US20070031882 Methods and compositions for treating AIDS and HIV-related disorders using 1414, 1481,1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784 or 2045 molecules |
| 02/08/2007 | US20070031860 G-protein coupled receptor and uses therefor |
| 02/08/2007 | US20070031859 Method for producing a population of homozygous stem cells having a pre-selected immunotype and/or genotype, cells suitable for transplant derived therefrom, and materials and methods using same |
| 02/08/2007 | US20070031811 Methods of inducing a t cell mediated immune response by administering antigen presenting b cells |
| 02/08/2007 | US20070031441 Immunotherapy based on dendritic cells |
| 02/08/2007 | US20070031438 Antibodies as chimeric effector cell receptors against tumor antigens |
| 02/08/2007 | US20070031429 Cancerous desease modifying antibodies |
| 02/08/2007 | US20070031428 Isolated monoclonal antibody produced by hybridoma deposit IDAC accession number 170505-01; binding assays; customization of therapy for each individual |
| 02/08/2007 | US20070031427 Cancerous disease modifying antibodies |
| 02/08/2007 | US20070031426 Isolated monoclonal antibody produced by hybridoma deposit IDAC accession number 170505-03; binding bioassays; customization of therapy designed for each individual; anticarcinogenic-, -tumor and -metastasis agents |
| 02/08/2007 | US20070031425 Cancerous disease modifying antibodies |
| 02/08/2007 | US20070031422 Selection of cells expressing heteromeric polypeptides |
| 02/08/2007 | US20070031414 DR5 antibodies and uses thereof |
| 02/08/2007 | US20070031409 Recombinant DNA-molecule complex for the expression of anti-human-interferon-gamma chimeric antibodies or antibody fragments |
| 02/08/2007 | US20070031407 Peptide or protein containing a C'-D loop of the CD28 receptor family |
| 02/08/2007 | US20070031401 Metalloprotease catalytic site for use in identifying modulators for prevention and treatment of respiratory system disorders |
| 02/08/2007 | US20070031392 Delivery vehicle for recombinant proteins |
| 02/08/2007 | US20070031391 Using genetically engineered neural stem cells to track metastatic brain tumor cells by migrating throughout a brain tumor; antitumor agents |
| 02/08/2007 | US20070031390 Methods and compositions for site-specific genomic expression of nucleic acid sequences |
| 02/08/2007 | US20070031389 Using cardiac graft to treat and prevent scar tissue on heart; tissue engineering and regenerative medicine |
| 02/08/2007 | US20070031386 culturing a multilayer of human embryonic stem cells for a sufficient time to allow for the appearance of putative cells comprising brown pigment dispersed within their cytoplasm, culturing the putative cells to form a cell monolayer containing cells that are Pax6 negative and bestrophin positive |
| 02/08/2007 | US20070031376 In which IL-6R and IL-6 are directly linked without a linker; blood platelet proliferating agent, ex vivo amplifier for hematopoietic stem cells |
| 02/08/2007 | US20070031335 Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers |
| 02/08/2007 | US20070029256 Composite porous membrane and process for producing the same |
| 02/08/2007 | DE102005036880A1 Stereoselektive Synthese von chiralen Diolen Stereoselective synthesis of chiral diols |
| 02/08/2007 | CA2620937A1 Cancerous disease modifying antibodies |
| 02/08/2007 | CA2619951A1 Methods and apparatus for reducing protein content in sperm cell extenders |
| 02/08/2007 | CA2618050A1 Antibodies directed against an ldl receptor |
| 02/08/2007 | CA2618044A1 Antibodies directed against a ldl receptor |
| 02/08/2007 | CA2617583A1 Method for identifying regulatory t cells |
| 02/08/2007 | CA2617541A1 Method for isolating stem cells from cryopreserved dental tissue |
| 02/08/2007 | CA2617462A1 Cancerous disease modifying antibodies |
| 02/08/2007 | CA2617458A1 Cancerous disease modifying antibodies |
| 02/08/2007 | CA2617454A1 Cancerous disease modifying antibodies |
| 02/08/2007 | CA2617447A1 Cancerous disease modifying antibodies |
| 02/08/2007 | CA2617446A1 Cancerous disease modifying antibodies |
| 02/08/2007 | CA2617108A1 Method for regenerating an immune system |
| 02/08/2007 | CA2617056A1 Gtpase inhibitors and methods of use and crystal structure of rac-1 gtpase |
| 02/08/2007 | CA2616799A1 Improved methods and compositions for increasing longevity and protein yield from a cell culture |
| 02/08/2007 | CA2615549A1 Transition state structure of 5'-methylthioadenosine/s-adenosylhomocysteine nucleosidases |
| 02/08/2007 | CA2614666A1 Inflammation |
| 02/08/2007 | CA2547043A1 A plasma source and applications thereof |
| 02/07/2007 | EP1749888A2 Soluble zalpha11 cytokine receptors |
| 02/07/2007 | EP1749886A2 Polypeptides having kinase activity, their preparation and use |
| 02/07/2007 | EP1749884A1 Differentiation of bone marrow cells into neuronal cells and uses therefor |
| 02/07/2007 | EP1749840A2 Recombinant il-5 antagonists useful in treatment of il-5 mediated disorders |
| 02/07/2007 | EP1749838A1 Interleukin-18-receptor proteins |
| 02/07/2007 | EP1749836A2 Recombinant vascular endothelial cell growth factor D (VEGF-D) |
| 02/07/2007 | EP1749538A1 Methods of inducing differentiation of regulatory t-cells and proliferating the same with gpi anchor protein agonist and medicinal composition therefor |
| 02/07/2007 | EP1749537A1 Anti-idiotypics antibodies having a neutralising activity against factor VIII inhibitor antibody |
| 02/07/2007 | EP1749534A2 Use of parasitic biological agents for prevention and control of autoimmune diseases |
| 02/07/2007 | EP1749524A2 Inflammation-inhibiting compounds |
| 02/07/2007 | EP1749091A1 Feeder independent extended culture of embryonic stem cells |
| 02/07/2007 | EP1749090A2 Cell therapy formulation method and composition |
| 02/07/2007 | EP1749089A2 Methods and devices for culturing stem cells |
| 02/07/2007 | EP1749088A2 Expansion of neural stem cells with lif |